Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 39

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 39
---
12) | Consists of 72,888 shares of Class A common stock subject to options exercisable within 60 days of the Record Date held by Dr. Morrissey. |

| (13) | Consists of (i) 2,987 shares of Class A common stock held directly by Ms. Oliger and (ii) 7,638 shares of Class A common stock subject to options exercisable within 60 days of the Record Date held by Ms. Oliger. |

| (14) | Consists of (i) 8,435,236 shares of Class A common stock beneficially owned by our current executive officers and directors and (ii) 2,347,975 shares of Class A common stock subject to options exercisable within 60 days of the Record Date and held by our executive officers and directors. |

25

TABLE OF CONTENTS Delinquent Section 16(a) Reports Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of certain changes in ownership of common stock and other equity securities of our company. Officers, directors and greater than ten percent stockholders are required by SEC regulation to furnish our company with copies of all Section 16(a) forms they file. To our knowledge, based solely on a review of the copies of such reports filed on the SEC’s EDGAR system and written representations that no other reports were required, during the fiscal year ended December 31, 2024, all Section 16(a) filing requirements applicable to our officers, directors and greater than ten percent beneficial owners were complied with, except that one Form 4, filed on January 8, 2024, relating to the acquisition of an option to purchase 350,000 shares of the Company’s Class A common stock on January 3, 2024, was filed late by Robert Brenner and one Form 4, filed on April 5, 2024, relating to transfer of 1,620 shares of the Company’s Class A common stock from a trust for which Sean Grant serves as trustee to an account for which Sean Grant serves a custodian pursuant to the Uniform Transfers to Minors Act on July 24, 2023 and relating to the disposition of 636 shares of our Class A common stock by a trust for which Sean Grant serves as trustee on December 20, 2023.